Autor: |
Berger Marc A, Tario Joseph D, Vasilakos John P, Ramakrishna Venky, Wallace Paul K, Keler Tibor |
Jazyk: |
angličtina |
Rok vydání: |
2007 |
Předmět: |
|
Zdroj: |
Journal of Translational Medicine, Vol 5, Iss 1, p 5 (2007) |
Druh dokumentu: |
article |
ISSN: |
1479-5876 |
DOI: |
10.1186/1479-5876-5-5 |
Popis: |
Abstract Previously, we have successfully targeted the mannose receptor (MR) expressed on monocyte-derived dendritic cells (DCs) using a fully human MR-specific antibody, B11, as a vehicle to deliver whole protein tumor antigens such as the human chorionic gonadotropin hormone (hCGβ). Since MRs play a role in bridging innate immunity with adaptive immunity we have explored several toll-like receptor (TLR)-specific ligands that may synergize with MR targeting and be applicable as adjuvants in the clinic. We demonstrate that antigen-specific helper and cytolytic T cells from both healthy donors and cancer patients were effectively primed with B11-hCGβ-treated autologous DCs when a combination of one or several TLR ligands is used. Specifically, concomitant signaling of DCs via TLR3 with dsRNA (poly I:C) and DC TLR 7/8 with Resiquimod (R-848), respectively, elicited efficient antigen presentation-mediated by MR-targeting. We demonstrate that MR and TLRs contribute towards maturation and activation of DCs by a mechanism that may be driven by a combination of adjuvant and antibody vaccines that specifically deliver antigenic targets to DCs. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|